Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission

AIDS Research and Human Retroviruses

Volumn 17, Issue 10, 2001, Pages 911-923

  Yedavalli, V R K ^a   Ahmad, N ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTIRETROVIRUS AGENT; ARGININE; ASPARAGINE; GLYCINE; HISTIDINE; LYSINE; SERINE; TYROSINE; VIF PROTEIN; VPR PROTEIN; ZIDOVUDINE;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CONTROLLED STUDY; DELIVERY; DISEASE TRANSMISSION; FEMALE; GENE FUNCTION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTHER; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; START CODON; STOP CODON; VERTICAL TRANSMISSION;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; CONSERVED SEQUENCE; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENE PRODUCTS, VIF; GENE PRODUCTS, VPR; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STATISTICS;

EID: 0034835569     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750290032     Document Type: Article

References (72)

1. Maternal-fetal transmission of human immunodeficiency virus
2. Molecular mechanisms of human immunodeficiency virus mother-infant transmission
3. Epidemiology of HIV infection and AIDS: Incubation and infectious periods, survival and vertical transmission
4. A prospective study of infants born to women seropositive for human and immunological virus type 1
5. HIV in pregnant women and their offsprings: Evidence for late transmission
6. Mother to child transmission of HIV-1
7. Epidemiology, clinical features and prognostic factors of pediatric HIV infection
8. Postnatal transmission of HIV from mother to child
9. Infants born to mothers seropositive for human immunodeficiency virus - Preliminary findings from a multiculture European study
10. Maternal viral load, zidovudine treatment and risk of transmission of human immunodeficiency virus type 1 from mother to infant
11. Selective vertical transmission of HIV-1 antiretroviral resistance mutations
12. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
13. Maternal viral load and vertical transmission: An important factor but not the only one
14. Maternal factors associated with perinatal HIV-1 transmission: The French Cohort Study: 7 Years of follow up observation
15. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission
16. Selective transmission of human immunodeficiency virus type 1 variants from mother to infants
17. Comparison of varible region 3 sequences of human immuno-deficiency virus type 1 from infected children with RNA/DNA sequences of virus population of their mothers
18. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intrauterine virus transmission
19. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child
20. Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants by vertical transmission
21. Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1
22. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease
23. Rapid generation of sequence variation during primary HIV-1 infection
24. HIV-1 genomic RNA diversification following sexual and parental virus transmission
25. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection
26. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
27. Conservation of amino acid sequences motifs in lentivirus Vif proteins
28. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo
29. In vivo genetic variability of the HIV-1 vif gene
30. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo
31. Gene acquisition in HIV and SIV
32. Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission
33. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission
34. Thesor gene of HIV-1 is required for efficient virus transmission in vitro
35. Role of vif in replication of human immunodeficiency virus type 1 CD4+ T lymphocytes
36. Replicative and cytopathic potential of HTLV III/LAV with sor gene deletions
37. The HIV "A" (sor) gene product is essential for virus infectivity
38. Essential role of Vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocytes/macrophages
39. Vif is critical for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
40. Viral protein R of human immunodeficiency virus type 1 and 2 is dispensible for replication and cytopathogenicity
41. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
42. Distinct effects in primary macrophages and lymphocytes of human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: Mutational analysis of a primary HIV-1 isolate
43. Antisense phosphorothioate oligonucleotides targeted to the vpr gene inhibit human immunodeficiency
44. Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes
45. Mutational analysis of the cell cycle, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
46. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in non-dividing host cells
47. The human immunodeficiency virus type 1 vpr arrests infected T cells in the G2/M phase of the cell cycle
48. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection
49. An HIV-1 infected long-term non-progressor (LTNP): Molecular analysis of HIV-1 strains in the vpr and nef genes
50. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: In vivo evolution of vpr quasispecies in blood and plasma
51. Gross defects in the vif and vpr genes of HIV type 1 cannot explain the differences in RNA copy number long-term asymptomatics and progressors
52. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection
53. Characterization of human immunodeficiency type 1 involved in maternal-fetal transmission
54. Classification system for HIV in children under 13 years of age
55. Human immunodeficiency virus type 1 genetic evolution in children with divergent rates of development of disease
56. Simple methods for estimating the number of synonymous and nonsynonymous nucleotide substitutions
57. Variance and covariances of the numbers of synonymous and nonsynonymous substitutions per site
58. PHYLIP - Phylogenetic inference package
59. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity
60. Phosphorylation of Vif and its role in HIV-1 replication
61. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains
62. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes growth arrest and structural defects
63. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr
64. Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation
65. Characterization of mother-infant HIV-1 type 1 sequences associated with perinatal transmission
66. Protecting HIV databases
67. Maintaining the integrity of human immunodeficiency virus sequence database
68. A high frequency of defective vif genes in peripheral blood mononuclear cells from HIV type 1-infected individuals
69. Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda
70. Limited heterogeneity and HIV-1 type in infected mothers correlates with lack of vertical transmission